Johnson & Johnson Anticipates New Psoriasis Pill to Be a Major Drug

Johnson & Johnson believes its new psoriasis pill, Icotyde, has the potential to become one of its most significant drugs. Investors are closely watching such new medications to boost the company's revenue growth.